Robinson James A. Jr. 4
4 · UroGen Pharma Ltd. · Filed Dec 1, 2025
Insider Transaction Report
Form 4
Robinson James A. Jr.
Director
Transactions
- Exercise/Conversion
ordinary shares
2025-11-26+2,000→ 2,000 total - Exercise/Conversion
Restricted Stock Unit
2025-11-26−2,000→ 6,000 total→ Ordinary Shares (2,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer